Genetic assessment of young athletes who experience sudden cardiac arrest during sports
Official title: Registre Prospectif français Des Morts Subites Chez Des Sportifs Jeunes
Run by Rennes University Hospital · NCT06642168 · Data updated 2026-11-12
This study looks at young athletes aged 12 to 35 who have had sudden cardiac arrest during sports to see if genetic factors played a role and to help prevent similar events in others.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 12 Years to 35 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Rennes University Hospital Academic / other |
| Locations | 26 sites (Nîmes, France and 25 other locations) |
| Status | Recruiting |
| Started | October 11, 2024 |
| Main results expected | January 11, 2028 |
| Study ends | January 11, 2028 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT06642168 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are young athletes aged 12 to 35 who have experienced a sudden cardiac arrest during or shortly after sports activities without any known cardiovascular pathology.
✕Probably not a fit
Patients who have pre-existing cardiovascular conditions or are older than 35 years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry focuses on young individuals aged 12 to 35 who suffer from sudden cardiac arrest (SCA) or sudden cardiac death (SCD) related to sports activities. The study aims to identify the underlying causes of these events through comprehensive etiological assessments, including autopsies, whole exome genetic analysis, and toxicological testing. By understanding the genetic factors involved, the study seeks to provide insights that could help prevent similar incidents in family members of victims. The findings will contribute to a better understanding of the risks associated with sports participation in young athletes.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention strategies for sudden cardiac events in young athletes and their families.
How similar studies have gone: While studies on sudden cardiac arrest in athletes exist, this specific approach focusing on genetic assessment in young victims is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Victims of SCA: * Aged between 12 and 35 years * No known cardiovascular pathology * Experienced a sudden and non-traumatic SCA during or within one hour of participating in sports activities (leisure, training, or competition) * For resuscitated victims (SCA group): A person or legal representative who does not oppose participation in the research after being informed about the study (including individuals, organs, or authorities responsible for assisting or representing them if they are unable to express their wishes). * For non-resuscitated victims (SCD group): A person who has not formally objected to the reuse of their medical data during their lifetime. * First-Degree Relatives: * A person or legal representative who does not oppose participation in the research after being informed about the study (including individuals, bodies, or authorities responsible for assisting or representing them if they are unable to express their wishes). Non-Inclusion Criteria: * For resuscitated SCA cases, individuals weighing less than 20 kg * Victims or legal representatives who are subject to legal protection or deprived of their liberty
Where it's running
-
APHP Hôpital Européen Georges Pompidou
Paris, France, France Recruiting -
CHU Rennes
Rennes, France, France Recruiting -
CHU Bordeaux
Bordeaux, France Recruiting -
CHU Caen
Caen, France Recruiting -
CHU Clermont-Ferrand
Clermont-Ferrand, France Recruiting -
CHRU Lille
Lille, France Recruiting
Show 20 more locations
-
APHM Hôpitaux universitaires de Marseille
Marseille, France Recruiting -
CHRU Montpellier
Montpellier, France Recruiting -
CHU Nantes
Nantes, France Recruiting -
CHU de Nice
Nice, France Recruiting -
APHP Hôpital Pitié-Salpêtrière
Paris, France Recruiting -
CHU Poitiers
Poitiers, France Recruiting -
CHU Saint-Etienne
Saint-Etienne, France Recruiting -
CHU Toulouse
Toulouse, France Recruiting -
CHRU Tours
Tours, France Recruiting -
CHU Nîmes
Nîmes, France, France Not yet recruiting -
APHP Hôpital Bichat
Paris, France, France Not yet recruiting -
CHU Brest
Brest, France Not yet recruiting -
APHP Hôpital Henri-Mondor
Créteil, France Not yet recruiting -
CHU Dijon Bourgogne
Dijon, France Not yet recruiting -
CHU de Grenoble Alpes
Grenoble, France Not yet recruiting -
Hospices Civils de Lyon
Lyon, France Not yet recruiting -
CHRU Nancy
Nancy, France Not yet recruiting -
CHU Reims
Reims, France Not yet recruiting -
CHU Rouen
Rouen, France Not yet recruiting -
CHRU Strasbourg
Strasbourg, France Not yet recruiting
Study contacts
- Principal investigator: Frédéric SCHNELL — Study Principal Investigator
- Study coordinator: Frédéric SCHNELL
- Email: frederic.schnell@chu-rennes.fr
- Phone: 0299284133
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting sudden cardiac arrest risk in people with coronary artery disease
This project will try to see if combining genetics, ECGs, blood biomarkers, imaging, and psychosocial information can predict which people with coronary artery disease are most likely to have sudden cardiac arrest.
-
Identifying risk factors for sudden cardiac arrest in coronary artery disease patients
This study is trying to find out what clinical and genetic factors might increase the risk of sudden cardiac arrest in people with coronary artery disease.
-
Registry and biobank for arrhythmogenic ventricular cardiomyopathy
This study is trying to gather information and samples from people with arrhythmogenic ventricular cardiomyopathy and their families to better understand the genetic causes of the condition and improve early diagnosis for those at risk.
-
Prehospital femoral arterial access to monitor blood pressure during OHCA
This pilot study tests whether placing a femoral arterial sheath before hospital arrival is feasible and safe in adults with non-traumatic OHCA to enable invasive blood pressure monitoring and better vasopressor control.
-
Left bundle branch pacing plus ICD for people with hypertrophic cardiomyopathy after myectomy
This study will test whether adding left bundle branch pacing to a dual‑chamber ICD helps people with hypertrophic cardiomyopathy who develop left bundle branch block after myectomy to slow heart failure progression and prevent life‑threatening arrhythmias.
-
Carvedilol versus metoprolol succinate in people with heart failure and an implanted defibrillator
This study will test whether switching from metoprolol succinate to carvedilol reduces ICD therapies, heart-related hospitalizations, or cardiovascular death in adults with HFrEF and an ICD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.